Skip to content

The Efficacy of Topical Serum X for Skin Brightening

The Efficacy of Topical Serum X Containing Arbutin and Glutathione for Skin Brightening

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05693948
Enrollment
34
Registered
2023-01-23
Start date
2022-09-01
Completion date
2023-09-01
Last updated
2023-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Aesthetic, Cosmetic

Brief summary

This study is conducted to evaluate the effectiveness of topical serum X containing arbutin and glutathione for skin brightening. The study duration is 12 weeks and the skin assessment will be carried out at baseline, week 4, 8 and week 12.The main questions this study aims to answer are: 1. The skin brightening effect of the product on facial skin. 2. To observe any adverse effect occurrence with the usage of the product.

Interventions

OTHEROther: Serum X

Serum X contain arbutin and glutathione

Sponsors

Ungku Shahrin Medical Aesthetic Research & Innovation (USMARI) Centre
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* Malaysia citizen * Male and female (age 18-30 years old)

Exclusion criteria

* Participant with severe acne skin condition * Participant who is taking isotretinoin, immunocompromised patients and received laser and light treatment within the last three months * Participant who undergo whitening or cosmetic treatments such as botox and dermal fillers within the previous six month * Participant with a history of facial surgery such as facelift or nose reshaping * Participant with history of allergies to any ingredient in the study product * Participant who is pregnant or plan to get pregnant

Design outcomes

Primary

MeasureTime frameDescription
Changes in skin tone from baseline and at week 4, week 8, and week 12 after usage of serum X.Baseline and at week 4, week 8, and week 12Skin tone will be assessed using JANUS III skin analyzer
Adverse effect after using serum XWeek 12Based on adverse effect occurrence on participants that occur during study period (12 weeks

Countries

Malaysia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026